REPORT ID 2360

United States Nuclear Receptor ROR Gamma Market Report 2017

Publish Date
8-Dec-17
Pages
108
Format
Electronic (PDF)

In this report, the United States Nuclear Receptor ROR Gamma market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
    The West
    Southwest
    The Middle Atlantic
    New England
    The South
    The Midwest
with sales (volume), revenue (value), market share and growth rate of Nuclear Receptor ROR Gamma in these regions, from 2012 to 2022 (forecast).

United States Nuclear Receptor ROR Gamma market competition by top manufacturers/players, with Nuclear Receptor ROR Gamma sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Genfit SA
    GlaxoSmithKline Plc
    Aurigene Discovery Technologies Ltd
    Beijing Hanmi Pharmaceutical Co Ltd
    Biogen Inc
    AbbVie Inc
    Advinus Therapeutics Ltd
    Brickell Biotech Inc
    Pfizer Inc
    Phenex Pharmaceuticals AG
    Reata Pharmaceuticals Inc
    Bristol-Myers Squibb Company
    Celgene Corp
    Eli Lilly and Company
    Glenmark Pharmaceuticals Ltd
    Lead Pharma Holding BV

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    BBI-6000
    GRC-39815Action
    R&D Progress
    GSK-2981278
    IMU-366
    INV-17
    Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Chronic Obstructive Pulmonary Disease
    Asthma
    Axial Spondyloarthritis
    Breast Cancer
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

United States Nuclear Receptor ROR Gamma Market Report 2017
1 Nuclear Receptor ROR Gamma Overview
    1.1 Product Overview and Scope of Nuclear Receptor ROR Gamma
    1.2 Classification of Nuclear Receptor ROR Gamma by Product Category
        1.2.1 United States Nuclear Receptor ROR Gamma Market Size (Sales Volume) Comparison by Type (2012-2022)
        1.2.2 United States Nuclear Receptor ROR Gamma Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
        1.2.3 BBI-6000
        1.2.4 GRC-39815Action
        1.2.5 R&D Progress
        1.2.6 GSK-2981278
        1.2.7 IMU-366
        1.2.8 INV-17
        1.2.9 Others
    1.3 United States Nuclear Receptor ROR Gamma Market by Application/End Users
        1.3.1 United States Nuclear Receptor ROR Gamma Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
        1.3.2 Chronic Obstructive Pulmonary Disease
        1.3.3 Asthma
        1.3.4 Axial Spondyloarthritis
        1.3.5 Breast Cancer
        1.3.6 Others
    1.4 United States Nuclear Receptor ROR Gamma Market by Region
        1.4.1 United States Nuclear Receptor ROR Gamma Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 The West Nuclear Receptor ROR Gamma Status and Prospect (2012-2022)
        1.4.3 Southwest Nuclear Receptor ROR Gamma Status and Prospect (2012-2022)
        1.4.4 The Middle Atlantic Nuclear Receptor ROR Gamma Status and Prospect (2012-2022)
        1.4.5 New England Nuclear Receptor ROR Gamma Status and Prospect (2012-2022)
        1.4.6 The South Nuclear Receptor ROR Gamma Status and Prospect (2012-2022)
        1.4.7 The Midwest Nuclear Receptor ROR Gamma Status and Prospect (2012-2022)
    1.5 United States Market Size (Value and Volume) of Nuclear Receptor ROR Gamma (2012-2022)
        1.5.1 United States Nuclear Receptor ROR Gamma Sales and Growth Rate (2012-2022)
        1.5.2 United States Nuclear Receptor ROR Gamma Revenue and Growth Rate (2012-2022)

2 United States Nuclear Receptor ROR Gamma Market Competition by Players/Suppliers
    2.1 United States Nuclear Receptor ROR Gamma Sales and Market Share of Key Players/Suppliers (2012-2017)
    2.2 United States Nuclear Receptor ROR Gamma Revenue and Share by Players/Suppliers (2012-2017)
    2.3 United States Nuclear Receptor ROR Gamma Average Price by Players/Suppliers (2012-2017)
    2.4 United States Nuclear Receptor ROR Gamma Market Competitive Situation and Trends
        2.4.1 United States Nuclear Receptor ROR Gamma Market Concentration Rate
        2.4.2 United States Nuclear Receptor ROR Gamma Market Share of Top 3 and Top 5 Players/Suppliers
        2.4.3 Mergers & Acquisitions, Expansion in United States Market
    2.5 United States Players/Suppliers Nuclear Receptor ROR Gamma Manufacturing Base Distribution, Sales Area, Product Type

3 United States Nuclear Receptor ROR Gamma Sales (Volume) and Revenue (Value) by Region (2012-2017)
    3.1 United States Nuclear Receptor ROR Gamma Sales and Market Share by Region (2012-2017)
    3.2 United States Nuclear Receptor ROR Gamma Revenue and Market Share by Region (2012-2017)
    3.3 United States Nuclear Receptor ROR Gamma Price by Region (2012-2017)

4 United States Nuclear Receptor ROR Gamma Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
    4.1 United States Nuclear Receptor ROR Gamma Sales and Market Share by Type (Product Category) (2012-2017)
    4.2 United States Nuclear Receptor ROR Gamma Revenue and Market Share by Type (2012-2017)
    4.3 United States Nuclear Receptor ROR Gamma Price by Type (2012-2017)
    4.4 United States Nuclear Receptor ROR Gamma Sales Growth Rate by Type (2012-2017)

5 United States Nuclear Receptor ROR Gamma Sales (Volume) by Application (2012-2017)
    5.1 United States Nuclear Receptor ROR Gamma Sales and Market Share by Application (2012-2017)
    5.2 United States Nuclear Receptor ROR Gamma Sales Growth Rate by Application (2012-2017)
    5.3 Market Drivers and Opportunities

6  United States Nuclear Receptor ROR Gamma Players/Suppliers Profiles and Sales Data
    6.1 Genfit SA
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Nuclear Receptor ROR Gamma Product Category, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Genfit SA Nuclear Receptor ROR Gamma Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 GlaxoSmithKline Plc
        6.2.2 Nuclear Receptor ROR Gamma Product Category, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 GlaxoSmithKline Plc Nuclear Receptor ROR Gamma Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Aurigene Discovery Technologies Ltd
        6.3.2 Nuclear Receptor ROR Gamma Product Category, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Aurigene Discovery Technologies Ltd Nuclear Receptor ROR Gamma Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Beijing Hanmi Pharmaceutical Co Ltd
        6.4.2 Nuclear Receptor ROR Gamma Product Category, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Beijing Hanmi Pharmaceutical Co Ltd Nuclear Receptor ROR Gamma Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Biogen Inc
        6.5.2 Nuclear Receptor ROR Gamma Product Category, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Biogen Inc Nuclear Receptor ROR Gamma Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 AbbVie Inc
        6.6.2 Nuclear Receptor ROR Gamma Product Category, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 AbbVie Inc Nuclear Receptor ROR Gamma Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Advinus Therapeutics Ltd
        6.7.2 Nuclear Receptor ROR Gamma Product Category, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Advinus Therapeutics Ltd Nuclear Receptor ROR Gamma Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Brickell Biotech Inc
        6.8.2 Nuclear Receptor ROR Gamma Product Category, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Brickell Biotech Inc Nuclear Receptor ROR Gamma Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 Pfizer Inc
        6.9.2 Nuclear Receptor ROR Gamma Product Category, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Pfizer Inc Nuclear Receptor ROR Gamma Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 Phenex Pharmaceuticals AG
        6.10.2 Nuclear Receptor ROR Gamma Product Category, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 Phenex Pharmaceuticals AG Nuclear Receptor ROR Gamma Sales, Revenue, Price and Gross Margin (2012-2017)
        6.10.4 Main Business/Business Overview
    6.11 Reata Pharmaceuticals Inc
    6.12 Bristol-Myers Squibb Company
    6.13 Celgene Corp
    6.14 Eli Lilly and Company
    6.15 Glenmark Pharmaceuticals Ltd
    6.16 Lead Pharma Holding BV

7 Nuclear Receptor ROR Gamma Manufacturing Cost Analysis
    7.1 Nuclear Receptor ROR Gamma Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Nuclear Receptor ROR Gamma

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Nuclear Receptor ROR Gamma Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Nuclear Receptor ROR Gamma Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 United States Nuclear Receptor ROR Gamma Market Size (Value and Volume) Forecast (2017-2022)
    11.1 United States Nuclear Receptor ROR Gamma Sales Volume, Revenue Forecast (2017-2022)
    11.2 United States Nuclear Receptor ROR Gamma Sales Volume Forecast by Type (2017-2022)
    11.3 United States Nuclear Receptor ROR Gamma Sales Volume Forecast by Application (2017-2022)
    11.4 United States Nuclear Receptor ROR Gamma Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer